Vaccine Effective Against Delta Variant Of Coronavirus: US Study

The research that used national data also indicates that Moderna's vaccine is significantly more effective against Delta variant than Pfizer and Johnson & Johnson preventives.

COVID-19 vaccines are effective at preventing hospitalisations and emergency department visits caused by the Delta variant of the SARS-CoV-2 virus, according to a US study. The research that used national data also indicates that Moderna's vaccine is significantly more effective against Delta variant than Pfizer and Johnson & Johnson preventives. "These real-world data show that vaccines remain highly effective at reducing COVID-19 related hospitalisations and emergency department visits, even in the presence of the new COVID-19 variant," said study author Shaun Grannis, vice president for data and analytics at Regenstrief Institute in the US. "We strongly recommend vaccinations for all who are eligible to reduce serious illness and ease the burden on our healthcare system," Grannis said in a statement.